Medizintechnik: Vorstandswechsel – Neue Chefin von Carl Zeiss Meditec startet noch dieses Jahr
Carl Zeiss Meditec bekommt zum 1. Dezember eine neue Chefin. Die Irin Bronwyn Brophy O'Connor löst Andreas Pecher ab, der das Unternehmen seit Jahresbeginn übergangsweise führt.
Frankfurt - Carl Zeiss Meditec, the medical technology arm of the Zeiss conglomerate, has announced a change at the top as it appointed Bronwyn Brophy O Connor as its new chief executive officer, effective December 1. The company revealed the appointment on Monday, following an announcement in May. However, the exact timing of her transition from her previous employer, the Swedish reproductive medicine firm Vitrolife, depended on negotiations with Vitrolife, which currently has Andreas Pecher serving as interim CEO.
Pecher also oversees Carl Zeiss AG, the parent company, and implemented a cost-cutting program that could eliminate up to 1,000 positions at the subsidiary. Upon assuming her role, Brophy O Connor will simultaneously join the executive board of the parent company, taking charge of the medical technology division. Hailing from Ireland, the physician has over 25 years of experience in the industry and previously worked for Thermo Fisher and Medtronic.
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
